NASDAQ · Medical - Devices

MASS (MASS) Stock

$8.30 -1.31% NASDAQ: MASS Healthcare

Valuation

MetricValue
Price$8.30
Market Cap$340.53M
P/E Ratio12.81
P/B Ratio1.82
P/S Ratio4.57
EPS (TTM)$0.54
52-Week High$9.34
52-Week Low$5.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.69%
ROA-19.47%
ROCE-16.67%
Gross Margin-42.86%
Operating Margin-42.86%
Net Margin-62.10%
Debt/Equity0.03
Current Ratio4.26

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$47.0M$50.0M$60.0M$56.0M
Operating Profit$-22.0M$-35.0M$-43.0M$-77.0M$-24.0M
Net Profit$-22.0M$-34.0M$-36.0M$-72.0M$-37.0M
EPS$-0.79$-1.07$-1.13$-2.12$0.54
Op Margin-52.3%-75.5%-85.1%-128.7%-43.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$261.0M$243.0M$203.0M$159.0M$190.0M
Total Liabilities$46.0M$52.0M$37.0M$45.0M$46.0M
Cash$224.0M$188.0M$121.0M$44.0M$113.0M
Borrowings$21.0M$20.0M$6.0M$7.0M$17.0M

Latest News

Mobile Mass Spectrometers Market by Application, Product Type & Component Global Forecast to 2031 GlobeNewswire · Jul 6, 2026 908 Devices (MASS) Upgraded to Buy: Here's Why Zacks · Jun 4, 2026 908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire · Jun 2, 2026 908 Devices MASS Q1 2026 Earnings Transcript Motley Fool · May 7, 2026 908 Devices Inc. Q1 2026 Earnings Call Summary Moby · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-29.0M$-21.0M$-25.0M$-30.0M$-24.0M
Investing Cash Flow$-1.0M$-18.0M$-28.0M$-47.0M$50.0M
Financing Cash Flow$94.0M$0$-2.0M$-2.0M$-2.0M
Net Cash Flow$65.0M$-36.0M$-67.0M$-77.0M$26.0M
Free Cash Flow$-30.0M$-23.0M$-27.0M$-31.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-3.19%
Quick Ratio3.25
Interest Coverage—
Return 1Y-3.00%
Return 3Y-5.83%
Return 5Y-74.35%

Ownership

Insiders Held8.21%
Institutions Held82.81%
Institutions Float Held90.21%
Institutional HolderSharesReport Date
First Light Asset Management, LLC6,072,5632026-03-31
AWM Investment Company, Inc.5,199,9242026-03-31
ARK Investment Management, LLC1,946,6852026-03-31
Blackrock Inc.1,767,3162026-03-31
Needham Investment Management, L.L.C.1,240,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRS $5.91 -2.96% -6.68 $825.41M 0.00%
CAPR $3.93 -5.76% -50.70 $227.59M 0.00%
CERS $2.32 +2.20% -34.25 $467.54M 0.00%
CVRX $4.88 +2.95% -2.98 $129.50M 0.00%
NNOX $1.06 +3.92% -1.56 $73.78M 0.00%

About MASS

MASS is led by CEO Kevin J. Knopp, publicly traded since 2020.

MASS stock trades at $8.30 with a market capitalization of $340.53M. The stock is valued at a price-to-earnings (P/E) ratio of 12.81, price-to-book of 1.82, price-to-sales of 4.57. Over the past 52 weeks the stock has ranged between $5.03 and $9.34, and currently trades 11.1% below its 52-week high.

On profitability, MASS generates a return on equity (ROE) of -25.69%, return on capital employed of -16.67%, an operating margin of -42.86%, a net profit margin of -62.10%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides